ISB News

Dr. Lee Hood Among Top 10 Biotech Visionaries

Scientific American World View has compiled a list of the top 100 most-influential visionaries in biotech. The top 10 includes ISB President Dr. Lee Hood (page 11), as well as Bill and Melinda Gates, of the Gates Foundation; Francis Collins, of the U.S. National Institutes of Health; and Craig Venter, of the J. Craig Venter Institute. To see the full list, download the special issue: SA World View 2015

100K Wellness Project News: Arivale Launches

Geekwire.com posted coverage of the launch party of Arivale, a new “scientific wellness” company that ISB President Dr. Lee Hood and ISB Associate Director Dr. Nathan Price co-founded. “I think it’s going to be very big,” said Hood in an interview Monday afternoon at his office. “Arivale is the opening shot in a whole new industry called scientific wellness, and it really stands a chance of being the Google or…

ISB Q&A: Liesl Wilke

In March, ISB announced the launch of the Wilke Lyme Disease Project, which has received $2.13 million in transformational gifts from Jeff and Liesl Wilke; Jeff and MacKenzie Bezos; and the Bay Area Lyme Foundation to tackle chronic Lyme disease. Lyme is a highly complex and often misdiagnosed disease that can be debilitating for those who do not respond to a standard course of antibiotics. This funding for the Wilke…

Gustavo Glusman Promoted to Principal Scientist

By Dr. Lee Hood June 19, 2015 – It is an enormous delight for me to announce that Gustavo Glusman has been promoted to Principal Scientist. This is a new position that requires significant scientific accomplishments, a proven ability to raise money for one’s science and a commitment to the cross-disciplinary, open and participatory philosophy of the Institute. Gustavo fulfills these requirements in spades. He joins Monica Orellana and Kai…

A Mixture of Markers from Two Distinct Cell Types Indicates Poor Prognosis in Breast Cancer

3 Bullets: Identifying the most aggressive cells in cancer (cancer stem cells) is essential for designing effective therapy and predicting patient outcomes. Using single-cell analysis techniques, researchers at ISB and Luxembourg Centre for Systems Biomedicine have identified the molecular signatures of two types of malignant breast tissue cells. Researchers found an interesting twist: the two cell types “cooperate” to increase malignancy potential and they promote a third hybrid stem-cell type….

Genetic Switch May Help Marine Microalgae Respond to Higher CO2 Levels

3 Bullets Rapid climate change, including ocean acidification caused by increasing carbon dioxide (CO2) levels, is predicted to affect the oceans, sea life, and the global carbon cycle. Marine microalgae, including diatoms, are responsible for converting CO2 into oxygen and biologically usable carbon through photosynthesis. How these organisms will respond over the short and long term to rising CO2 is unknown. Growth experiments and transcriptomic analyses performed by UW and…

Monica Orellana Promoted to Principal Scientist

In her 11 years as a senior scientist in the Baliga lab at ISB, Monica has successfully developed a rigorous program on marine and oceanographic systems, and has been a pioneer in transcending traditional disciplinary boundaries and transferring systems methodology developed at ISB to explorecomplex oceanographic problems of global importance. Her highly collaborative and cross-disciplinary work involves laboratory and field studies that integrate physiological, molecular and physical-chemical approaches to understand…